Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva launches generic version of Differin for acne
Pharmabiz
Saturday, June 5, 2010 - 12:18pm
tags:
Teva Pharmaceuticals, Differin, Galderma, acne
Mid-size pharma firms emerge faster, perform better
Sify, India
Saturday, June 5, 2010 - 12:12pm
tags:
Sun Pharma, Glenmark, investors
Teva reports encouraging data from study assessing new lower-volume injection of Copaxone at 24th CMSC
News-Medical
Saturday, June 5, 2010 - 12:10pm
tags:
Teva Pharmaceuticals, Copaxone, multiple sclerosis
Botulinum Toxin Shows Some Potential Benefit for Low Back Pain
Pain Medicine News
Saturday, June 5, 2010 - 12:08pm
tags:
botulinum toxin A, Botox, Allergan
Ranbaxy recalls anti-nerve pain drug from UK
Trading Markets
Saturday, June 5, 2010 - 12:06pm
tags:
Ranbaxy, gabapentin
Roche says FDA approves HIV blood test
BusinessWeek
Saturday, June 5, 2010 - 12:04pm
tags:
Roche, HIV, blood testing
Biovail Enters into License Agreement with Kyowa Hakko Kirin
Pipeline Review
Saturday, June 5, 2010 - 12:00pm
tags:
Biovail, Kyowa Hakko Kirin, Parkinson's Disease, Istradefylline
Aoxing Pharmaceutical Company and Phoenix PharmaLabs, Inc. Announce Strategic Alliance to Co-Develop a Novel Class of Molecules in Pain and Drug Addiction Therapeutics
Pipeline Review
Saturday, June 5, 2010 - 11:57am
tags:
Aoxing, Phoenix PharmaLabs, pain management, addiction, opiods
Antibiotic Not Found to Reduce Breakthrough Bleeding
Modern Medicine
Saturday, June 5, 2010 - 11:55am
tags:
contraceptives, doxycycline
Options Alert for Teva Pharmaceutical Industries (TEVA)
Market Intellisearch
Saturday, June 5, 2010 - 11:52am
tags:
Teva Pharmaceuticals, investors
Drug Makers Provide View Of Sampling Practices .
WSJ
Saturday, June 5, 2010 - 10:25am
tags:
samples
Javelin Receives Notice From NYSE Amex LLC of Non-Compliance
Yahoo/BusinessWire
Saturday, June 5, 2010 - 10:23am
tags:
Javelin
The Changing Face of Abbott
Motley Fool
Saturday, June 5, 2010 - 10:18am
tags:
Abbott Laboratories
Out With Drugs, in With Medical Devices
Motley Fool
Saturday, June 5, 2010 - 10:15am
tags:
Medtronic, medical devices, JNJ, Boston Scientific, Abbott Laboratories, Nevo, drug eluting stents
This Cancer Drug's on a Roll
Motley Fool
Saturday, June 5, 2010 - 10:13am
tags:
Afinitor, pancreatic cancer, Novartis, Pfizer, Sutent
Sanofi Partners With Ascenta For Cancer Compounds
Forbes
Saturday, June 5, 2010 - 10:11am
tags:
Sanofi, Ascenta
Pharma News: Sanofi-Aventis, AstraZeneca (video)
Forbes
Saturday, June 5, 2010 - 10:09am
tags:
Sanofi, AstraZeneca
Data from Combination of REVLIMID® and Rituxan® in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma Presented at ASCO
Yahoo/BusinessWire
Saturday, June 5, 2010 - 9:59am
tags:
non-Hodgkin's lymphoma, Revlimid, Rituxan, Cellgene
Amgen Gets FDA Approval and SonoSite Has a New Frontier
Motley Fool
Saturday, June 5, 2010 - 9:50am
tags:
Amgen, denosumab, Prolia, SonoSite, ultrasound
Moody's downgrades Charles River ratings
Yahoo/AP
Saturday, June 5, 2010 - 9:48am
tags:
Charles River Laboratories, WuXi PharmaTech, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.